Navigation Links
University HealthSystem Consortium Selects KONE to Provide Elevator Maintenance Services
Date:3/20/2009

OAK BROOK, Ill., March 20 /PRNewswire/ -- The University HealthSystem Consortium (UHC) today announced that it has awarded a 3-year agreement to KONE Inc., an elevator and escalator manufacturing, installation, maintenance, modernization, and repair services company based in Lisle, Ill. The agreement, which has 2 optional 1-year renewal periods, became effective on February 1, 2009.

KONE operates 800 service centers in 50 countries, delivering approximately 50,000 new elevators and escalators and servicing more than 750,000 elevators and escalators and 270,000 automatic building doors per year.

A key benefit of the partnership with KONE is the KONE Care(TM) service program, which provides comprehensive and flexible service solutions for equipment regardless of manufacturer. In addition, KONE improves the environmental efficiency of its solutions by incorporating energy-saving technologies that keep the total cost of ownership low while reducing the environmental footprint of buildings.

"We're pleased to offer our members these important services from a trustworthy leader in the field," says Cindy White, vice president of operations at UHC. "KONE adds value with innovative, safe, and reliable solutions."

"KONE is excited to be a strategic partner of University HealthSystem Consortium," says Vance Tang, KONE executive vice president and area director for the Americas. "We look forward to helping UHC develop and improve their clinical operations through eco-efficient and reliable service solutions."

About UHC

The University HealthSystem Consortium (UHC), formed in 1984, is an alliance of 103 academic medical centers and 210 of their affiliated hospitals, representing approximately 90% of the nation's nonprofit academic medical centers. UHC offers its members specific programs and services to improve clinical, operational, financial, and patient safety performance. The mission of UHC is to advance knowledge, foster collaboration, and promote change to help members succeed in their respective markets. For more information, visit www.uhc.edu.

About KONE

KONE's objective is to offer the best people flow experience by developing and delivering solutions that enable people to move smoothly, safely, comfortably, and without waiting in buildings in an increasingly urbanizing environment. KONE provides its customers with industry-leading elevators, escalators, and innovative solutions for modernization and maintenance, and is one of the global leaders in its industry. In 2007, KONE had annual net sales of EUR 4.1 billion and more than 32,500 employees. KONE class B shares are listed on the NASDAQ OMX Helsinki Ltd in Finland. For more information, visit www.kone.com.


'/>"/>
SOURCE University HealthSystem Consortium
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University of Washington scientists one step closer to stopping bone loss during spaceflight
2. Syracuse University researchers build a new surface material that resists biofilm growth
3. TB vaccine developed at McMaster University in Canada
4. Centocor R&D and University of Michigan Forge New Model for Academic/Industry Partnerships
5. Western Governors University Addresses Rising Demand for Healthcare IT Professionals with B.S. in Health Informatics
6. DeVry University announces Employment Gap Scholarship program to aid displaced workers
7. University of Notre Dame Chooses Latest Technology From Carestream Molecular Imaging For Disease Research
8. University of Pennsylvania researchers find that the unexpected is a key to human learning
9. NorthShore University HealthSystem Launches Diabetes Outreach Program for Lake County's Medically Underserved
10. Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26
11. University of Maryland Business School Continues Executive Education Leadership With Maryland State Medical Society Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: